Assessment of Two Methods for Progesterone Dosage During IVF (SALIPROG)
Infertility
About this trial
This is an interventional diagnostic trial for Infertility focused on measuring Progesterone concentration, salivary test, In vitro fertilization, infertility
Eligibility Criteria
Inclusion Criteria: Adult patients between 18 and under 43 years old in the course of IVF more or less ICSI of the PMA service of the HFME with transfer of fresh embryo Signature of an express consent Understanding the French language, both oral and written. Affiliated to a social security scheme Exclusion Criteria: Persons deprived of their liberty by a judicial or administrative decision Persons subject to psychiatric care Persons admitted to a health or social establishment for purposes other than research Participants in another study that could impact the results of the present study, in particular those related to the level of progesterone. Adults subject to a legal protection measure (guardianship, curatorship)
Sites / Locations
- Hospital Femme Mère Enfant
Arms of the Study
Arm 1
Other
Salivary and blood progesterone dosage
IVF patients with fresh embryo transfer having a dosage of progesterone, salivary and blood, on triggering day